Quantitative Immunohistochemistry of PDGFRα, PDGFRβ, c-KIT and CSF1R in Human PAH Lung Samples

Quantitative Immunohistochemistry of PDGFRα, PDGFRβ, c-KIT and CSF1R in Human PAH Lung Samples

ERS – September 2022

Now Enrolling: The PROSERA Phase 3 study of seralutinib in adults with Pulmonary Arterial Hypertension (PAH).

PROSERA clinical trial: NCT05934526

Learn more about the study